Well Lead Medical Co., Ltd. (SHA:603309)
China flag China · Delayed Price · Currency is CNY
10.95
+0.02 (0.18%)
Nov 17, 2026, 3:00 PM CST

Well Lead Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,6321,6051,4801,3661,3541,106
Other Revenue
26.0726.0729.5221.979.6312.68
1,6581,6311,5091,3881,3631,119
Revenue Growth
1.07%8.07%8.76%1.79%21.88%-1.07%
Cost of Revenue
951.57911.03846.46762.64784.98646.82
Gross Profit
706.07720.15662.88625.1578.37471.76
Selling, General & Admin
308.25301.5288.14292.06286.47255.91
Research & Development
122.68115.66111.1194.9282.0755.03
Other Operating Expenses
18.4215.18.522.9114.0910.83
Operating Expenses
450.98434.29407.98390.68381.24322.6
Operating Income
255.09285.86254.9234.42197.13149.16
Interest Expense
-16.57-18.19-12.32-9.12-7.87-8.49
Interest & Investment Income
5.238.2512.3212.27.531.38
Currency Exchange Gain (Loss)
-6.55-6.555.070.917.4-1.64
Other Non Operating Income (Expenses)
-14.11-0.62-1.460.26-1.4-1.47
EBT Excluding Unusual Items
223.08268.74258.52238.67202.79138.94
Impairment of Goodwill
-146.95-146.95----
Gain (Loss) on Sale of Investments
1.71.590.620.081.94-4.84
Gain (Loss) on Sale of Assets
-0.3-0.36-0.910.09-0.070
Asset Writedown
-1.87---0.46-7.47-0.56
Other Unusual Items
7.277.274.82-1.088.466.69
Pretax Income
82.93130.28263.04237.3205.65140.22
Income Tax Expense
37.3343.1634.5732.727.925.55
Earnings From Continuing Operations
45.687.13228.47204.6177.75114.67
Minority Interest in Earnings
-12.6-10.8-9.08-12.12-11.18-8.58
Net Income
3376.33219.39192.49166.57106.09
Net Income to Common
3376.33219.39192.49166.57106.09
Net Income Growth
-86.49%-65.21%13.98%15.56%57.00%-30.71%
Shares Outstanding (Basic)
291294293292292259
Shares Outstanding (Diluted)
291294293292292259
Shares Change
-1.26%0.36%0.30%-0.20%12.93%-0.29%
EPS (Basic)
0.110.260.750.660.570.41
EPS (Diluted)
0.110.260.750.660.570.41
EPS Growth
-86.32%-65.33%13.64%15.79%39.02%-30.51%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
234.47124.11-9.47-135.38209.7578
Free Cash Flow Per Share
0.810.42-0.03-0.460.720.30
Dividend Per Share
0.3000.5000.5000.5000.3400.135
Dividend Growth
-57.14%0%0%47.06%151.85%-32.50%
Gross Margin
42.59%44.15%43.92%45.04%42.42%42.18%
Operating Margin
15.39%17.52%16.89%16.89%14.46%13.33%
Profit Margin
1.99%4.68%14.54%13.87%12.22%9.49%
Free Cash Flow Margin
14.14%7.61%-0.63%-9.75%15.38%6.97%
EBITDA
338.63362.09321.39297.58253.46198.48
EBITDA Margin
20.43%22.20%21.29%21.44%18.59%17.74%
D&A For EBITDA
83.5476.2366.563.1656.3349.32
EBIT
255.09285.86254.9234.42197.13149.16
EBIT Margin
15.39%17.52%16.89%16.89%14.46%13.33%
Effective Tax Rate
45.02%33.13%13.14%13.78%13.57%18.22%
Revenue as Reported
1,6581,6311,5091,3881,3631,119